Fujino Hiromichi
Department of Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
Bioessays. 2025 Sep;47(9):e70046. doi: 10.1002/bies.70046. Epub 2025 Jul 23.
In this article, onset mechanisms of colorectal cancer and intestinal bowel diseases (IBD) are postulated to involve the aberrant expression/hyper-activation of E-type prostanoid 4 (EP4) receptors. Although prostaglandin E and EP4 receptors are important factors for maintaining colorectal homeostasis, their mediated signaling is also considered to be involved in the etiology of severe intestinal diseases. To prevent uncontrollable activations of EP4 receptors, two safety factors are proposed: butyrate as an external safety factor and interleukin (IL)-4 as an internal safety factor. Thus, for maintaining vulnerable colorectal homeostasis, the levels of EP4 receptors, butyrate, and IL-4 are proposed as an important triad for protecting against development/onset risks of, at least, EP4 receptor-mediated cancer and IBD.
在本文中,结直肠癌和肠道疾病(IBD)的发病机制被假定涉及E型前列腺素4(EP4)受体的异常表达/过度激活。尽管前列腺素E和EP4受体是维持结肠直肠内环境稳定的重要因素,但其介导的信号传导也被认为与严重肠道疾病的病因有关。为防止EP4受体的失控激活,提出了两个安全因素:丁酸作为外部安全因素和白细胞介素(IL)-4作为内部安全因素。因此,为维持脆弱的结肠直肠内环境稳定,EP4受体、丁酸和IL-4的水平被认为是预防至少由EP4受体介导的癌症和IBD发生/发病风险的重要三联因素。